NCT05381753 2026-02-11
Safety and Efficacy of Avapritinib in Chinese Patients With Gastrointestinal Stromal Tumor (GIST) in the Real World
CStone Pharmaceuticals
Completed
Clinical Trials
16 trialsNCT05282108 2025-03-26
CARCML
Hikma Pharmaceuticals LLC
Recruiting
NCT06038552 2025-02-26
Comparison of Clinical Efficacy of Liver Resection, RFA, TACE, and Drug Therapy in Patients with GIST LM
First Affiliated Hospital, Sun Yat-Sen University
Completed
NCT06646978 2024-10-17
K2SPIRIT
Poitiers University Hospital
Enrolling by invitation
NCT06628739 2024-10-08
Correlation Between Imatinib Trough Concentration and Efficacy in Advanced GIST Patients with Different Genotypes
First Affiliated Hospital, Sun Yat-Sen University
Completed
NCT05286528 2023-10-27
Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: Analysis of National Health Insurance Fund Database
Pfizer
Completed
NCT05895942 2023-06-09
EMMBKM
Xijing Hospital
Unknown
NCT03885830 2023-01-11
Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients
UNC Lineberger Comprehensive Cancer Center
Completed
NCT01475110 2022-10-25
CML0609
Gruppo Italiano Malattie EMatologiche dell'Adulto
Completed
NCT05467189 2022-07-20
Antineoplastic Drugs in Elderly Patients
Shandong University
Recruiting
NCT03454503 2021-02-23
Effectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt
Hikma Pharmaceuticals LLC
Completed
NCT00632255 2019-07-08
Long Term Therapy With Imatinib: Development of Late Side Effects and Compliance to Treatment
Imperial College London
Completed
NCT03381053 2017-12-21
Study to Compare Pathologic Type, NIH and WHO Criteria,and Mechanism of GIST Malignant Transformation
Shanghai Zhongshan Hospital
Unknown
NCT03331211 2017-11-08
Observation of the Effect of Chemotherapy Combined With Tyrosinase Inhibitor on the Reactivation of CMV and EBV in Patients With Acute Lymphoblastic Leukemia
Nanfang Hospital, Southern Medical University
Unknown
NCT01188278 2016-09-30
Treatment With Second Generation Tyrosine Kinase Inhibitors (2G TKI) Post Imatinib Failure Survey
Bristol-Myers Squibb
Completed
NCT02146846 2016-09-07
Population Pharmacokinetics of Imatinib in CML Patients in Iran
Kerman University of Medical Sciences
Terminated